In addition, a recent study demonstrated that high ALDH1-expressing breast cancer cells preferentially survive both chemotherapy and radiation compared with low ALDH1-expressing cancer cells and a specific ALDH inhibitor (diethylaminobenzalaldehyde) may result in significant sensitization to therapy in the former cells (14). The gene discussed is ALDH1A1; the disease is breast carcinoma.